Merck Net Non-Operating Interest Income Expense (Quarterly) Analysis

Merck & Co., Inc. (MRK)

122.46 -1.47 (-1.19%) USD | NYSE | Feb 25, 16:00

122.55 +0.09 (+0.07%) Pre-Market: 04:51

View Net Non-Operating Interest Income Expense (Quarterly) for MRK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Biogen, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Cidara Therapeutics, Inc.	Upgrade
Moderna, Inc.	Upgrade